Title: Impact of TRIPS in India
Description: Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
Subjects: Industries, Drug Industry, Patents as Topic, Health Services Accessibility, International Cooperation, Legislation & jurisprudence, India, Pharmaceutical industry, Agreement on Trade-Related Aspects of Intellectual Property Rights, (1994), Pharmaceutical policy, Pharmaceutical & Biotechnology, BUSINESS & ECONOMICS, Drugs, prices, India, politics and government, Industrie pharmaceutique, Médicaments, Politique gouvernementale, Services de santé, Accessibilité, Coopération internationale, Development economics, Health economics, Welfare economics, Economics, Geistiges Eigentum, Handelspolitik, Pharmazeutische Industrie, TRIPS, Läkemedelsindustri, Immaterialrätt, Agreement on Trade-Related Aspects of Intellectual Property Rights (1994 April 15)
Places: India